172 related articles for article (PubMed ID: 14744727)
21. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions.
Min-min H; Ming-rong X; Ze-yi C; Kai-xuan Y; Zhi-lin S
Int J Gynecol Cancer; 2006; 16(6):2004-8. PubMed ID: 17177838
[TBL] [Abstract][Full Text] [Related]
22. MTHFR/p53 polymorphisms as genetic factors for cervical intraepithelial neoplasia and cervical cancer in HPV-infected Mexican women.
González-Herrera L; Rodríguez-Morales P; Gonza Lez-Losa Mdel R; Pérez-Mendoza G; Canul-Canché J; Rosado-López I; Cetina TC
Int J Biol Markers; 2014 Jun; 29(2):e142-9. PubMed ID: 24474455
[TBL] [Abstract][Full Text] [Related]
23. Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk.
Laprano TD; Lemos EH; Cunha LM; Júnior JE; de SousaTeles RA; Rabenhorst SH
Tumour Biol; 2014 Aug; 35(8):7435-40. PubMed ID: 24782034
[TBL] [Abstract][Full Text] [Related]
24. [P53 codon 72 polymorphism in cervical cancers and its correlation with HPV16,18E6].
Hou MM; Xi MR; Cao ZY; Yang KX; Sun ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):404-7. PubMed ID: 16761419
[TBL] [Abstract][Full Text] [Related]
25. P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women.
Roh JW; Kim BK; Lee CH; Kim J; Chung HH; Kim JW; Park NH; Song YS; Park SY; Kang SB
Oncol Res; 2010; 18(9):453-9. PubMed ID: 20524403
[TBL] [Abstract][Full Text] [Related]
26. The Association Between p53 Codon 72 Polymorphism and Endometrial Cancer Risk: A System Review and Meta-analysis.
Yi K; Yang L; Lan Z; Xi M
Int J Gynecol Cancer; 2016 Jul; 26(6):1121-8. PubMed ID: 27327151
[TBL] [Abstract][Full Text] [Related]
27. p53 codon 72 polymorphism interactions with dietary and tobacco related habits and risk of stomach cancer in Mizoram, India.
Malakar M; Devi KR; Phukan RK; Kaur T; Deka M; Puia L; Sailo L; Lalhmangaihi T; Barua D; Rajguru SK; Mahanta J; Narain K
Asian Pac J Cancer Prev; 2014; 15(2):717-23. PubMed ID: 24568485
[TBL] [Abstract][Full Text] [Related]
28. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
Jiang P; Liu J; Zeng X; Li W; Tang J
Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
[TBL] [Abstract][Full Text] [Related]
29. Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations.
Sousa H; Santos AM; Pinto D; Medeiros R
Int J Mol Med; 2007 Nov; 20(5):731-41. PubMed ID: 17912468
[TBL] [Abstract][Full Text] [Related]
30. Association between p53 polymorphism at codon 72 and recurrent spontaneous abortion.
Zhang Y; Wu YY; Qiao FY; Zeng WJ
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):402-405. PubMed ID: 27376811
[TBL] [Abstract][Full Text] [Related]
31. p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix.
Giannoudis A; Graham DA; Southern SA; Herrington CS
Int J Cancer; 1999 Sep; 83(1):66-9. PubMed ID: 10449610
[TBL] [Abstract][Full Text] [Related]
32. The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases.
Hu S; Zhao L; Yang J; Hu M
Meta Gene; 2013 Dec; 1():126-37. PubMed ID: 25606382
[TBL] [Abstract][Full Text] [Related]
33. Polymorphism at codon 72 of p53 is not associated with cervical cancer risk.
Malcolm EK; Baber GB; Boyd JC; Stoler MH
Mod Pathol; 2000 Apr; 13(4):373-8. PubMed ID: 10786802
[TBL] [Abstract][Full Text] [Related]
34. Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis.
Ruan XL; Li S; Geng P; Zeng XT; Yu GZ; Meng XY; Gao QP; Ao XB
Med Sci Monit; 2015 Oct; 21():3048-53. PubMed ID: 26451982
[TBL] [Abstract][Full Text] [Related]
35. A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese.
Suzuki K; Matsui H; Ohtake N; Nakata S; Takei T; Nakazato H; Okugi H; Koike H; Ono Y; Ito K; Kurokawa K; Yamanaka H
J Biomed Sci; 2003; 10(4):430-5. PubMed ID: 12824702
[TBL] [Abstract][Full Text] [Related]
36. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.
El khair MM; Ennaji MM; El kebbaj R; Mhand RA; Attaleb M; El Mzibri M
Med Oncol; 2010 Sep; 27(3):861-6. PubMed ID: 19771536
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the association between p53 codon 72 Arg>pro polymorphism and risk of ovary cancer: a meta-analysis.
Alqumber MA; Akhter N; Haque S; Panda AK; Mandal RK
PLoS One; 2014; 9(4):e94874. PubMed ID: 24747975
[TBL] [Abstract][Full Text] [Related]
38. P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians.
Xu T; Xu ZC; Zou Q; Yu B; Huang XE
Asian Pac J Cancer Prev; 2012; 13(5):2349-54. PubMed ID: 22901221
[TBL] [Abstract][Full Text] [Related]
39. No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer.
Jiang N; Pan J; Wang L; Duan YZ
Tumour Biol; 2013 Feb; 34(1):587-96. PubMed ID: 23192640
[TBL] [Abstract][Full Text] [Related]
40. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
